Latest news on Covid vaccine delay for kids; Door slammed shut for China-only data; Eric Lander is out; Looking back at the boom; and more
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up here.
We’ve been getting emails from readers asking about one of our most popular annual features — the Endpoints 20 under 40 — and when they can start nominating people. Well, the answer is now. Tell us about the fresh-faced academics or executives you believe are behind the next big idea here. The deadline is February 18.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 154,000+ biopharma pros reading Endpoints daily — and it's free.